Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone for Gulf War Illness
NCT01956279Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Gulf War syndrome (GWS) comparing Pregnenolone with Placebo (2 arms). Primary endpoint: Physical Component of the SF-36 at 8 weeks. Started Oct 2013; status: completed.
02
Drugs
pregnenolone
03
Conditions
Gulf War syndrome (GWS)
Beyond the preview
Go deeper on NCT01956279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01956279.